Cargando…
Special Issue “Anticancer Drugs 2021”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025550/ https://www.ncbi.nlm.nih.gov/pubmed/35455476 http://dx.doi.org/10.3390/ph15040479 |
_version_ | 1784690900690010112 |
---|---|
author | Meegan, Mary J. O’Boyle, Niamh M. |
author_facet | Meegan, Mary J. O’Boyle, Niamh M. |
author_sort | Meegan, Mary J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9025550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90255502022-04-23 Special Issue “Anticancer Drugs 2021” Meegan, Mary J. O’Boyle, Niamh M. Pharmaceuticals (Basel) Editorial MDPI 2022-04-14 /pmc/articles/PMC9025550/ /pubmed/35455476 http://dx.doi.org/10.3390/ph15040479 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Editorial Meegan, Mary J. O’Boyle, Niamh M. Special Issue “Anticancer Drugs 2021” |
title | Special Issue “Anticancer Drugs 2021” |
title_full | Special Issue “Anticancer Drugs 2021” |
title_fullStr | Special Issue “Anticancer Drugs 2021” |
title_full_unstemmed | Special Issue “Anticancer Drugs 2021” |
title_short | Special Issue “Anticancer Drugs 2021” |
title_sort | special issue “anticancer drugs 2021” |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025550/ https://www.ncbi.nlm.nih.gov/pubmed/35455476 http://dx.doi.org/10.3390/ph15040479 |
work_keys_str_mv | AT meeganmaryj specialissueanticancerdrugs2021 AT oboyleniamhm specialissueanticancerdrugs2021 |